Assessment of frailty status in non-geriatric peritoneal dialysis and hemodialysis patients

Abstract

Aims: The aim of this study was to evaluate and compare frailty status in non-geriatric hemodialysis (HD) and peritoneal dialysis (PD) patients and to assess whether there is a difference between frail and non-frail patients in HD and PD patients. Methods: 28 PD and 28 HD patients were included in this cross-sectional study. The Edmonton Frailty Scale (EFS) was used to assess frailty status, including questions on cognition, general health status, addiction, social support, medication, nutrition, depression and sphincter continence, and a physical test assessing standing and walking. Results: The mean age was 51.3+9.6 years and 24 (43%) of the individuals were female. There was no difference between HD and PD patients in terms of EFS score. Twelve (43%) of HD patients and 10 (36%) of PD patients were found to be frail (p=0.784). There was a positive correlation between age and EFS score in both HD and PD patients (r=0.896, p<0.001, r=0.661, p<0.001, respectively). In HD patients, there was a correlation between the EFS score and HbA1c (r=0.570, p=0.002). In HD patients, frail patients were older, had lower creatinine values and higher HbA1c levels (p<0.001, p=0.008, and p=0.006, respectively), while in PD patients, frail patients were older (p<0.001). Conclusion: There was no difference in frailty between HD and PD patients. It should be noted that frailty is common in nongeriatric dialysis patients. Measuring frailty may help clinicians to identify vulnerable patients and intervene early to mitigate adverse outcomes.

Keywords

• Frailty
• hemodialysis
• peritoneal dialysis
• non-geriatric frailty

Supporting Institution

None

Ethical Statement

The study protocol was approved by the Malatya Turgut Ozal University Faculty of Medicine Ethics Committee on July 10, 2024 (Approval number: 45).

Thanks

We thank all the participants who took part in this study.

References

1. Karnabi P, Massicotte-Azarniouch D, Ritchie LJ, Marshall S, Knoll GA. Physical frailty and functional status in patients with advanced chronic kidney disease: a systematic review. Can J Kidney Health Dis. 2023;10: 20543581231181026. doi:10.1177/20543581231181026
2. Markossian TW, Samra MK, Huisingh-Scheetz M, Wadhwa A. Framework to reduce frailty in hemodialysis patients. Nephrol Dial Transplant. 2022;37(8):1396-1399. doi:10.1093/ndt/gfac137
3. Walston J, Hadley EC, Ferrucci L, et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on aging research conference on frailty in older adults. J Am Geriatr Soc. 2006;54(6):991-1001. doi:10.1111/j.1532-5415.2006.00745.x
4. Kooman JP, Kotanko P, Schols AM, Shiels PG, Stenvinkel P. Chronic kidney disease and premature ageing. Nat Rev Nephrol. 2014;10(12):732-742. doi:10.1038/nrneph.2014.185
5. Kim JC, Kalantar-Zadeh K, Kopple JD. Frailty and protein-energy wasting in elderly patients with end stage kidney disease. J Am Soc Nephrol. 2013;24(3):337-351. doi:10.1681/ASN.2012010047
6. Mansur HN, Damasceno VdO, Bastos MG. Prevalência da fragilidade entre os pacientes com doença renal crônica em tratamento conservador e em diálise. J Bras Nefrol. 2012;34(2):153-160. doi:10.1590/s0101-28002012000200008
7. Musso CG, Jauregui JR, Macías Núñez JF. Frailty phenotype and chronic kidney disease: a review of the literature. Int Urol Nephrol. 2015;47(11): 1801-1807. doi:10.1007/s11255-015-1112-z
8. Bao Y, Dalrymple L, Chertow GM, Kaysen GA, Johansen KL. Frailty, dialysis initiation, and mortality in end-stage renal disease. Arch Intern Med. 2012;172(14):1071-1077. doi:10.1001/archinternmed.2012.3020

9. Rolfson DB, Majumdar SR, Tsuyuki RT, Tahir A, Rockwood K. Validity and reliability of the Edmonton frail scale. Age Ageing. 2006;35(5):526-529. doi:10.1093/ageing/afl041
10. Wu PY, Chao CT, Chan DC, Huang JW, Hung KY. Contributors, risk associates, and complications of frailty in patients with chronic kidney disease: a scoping review. Ther Adv Chronic Dis. 2019;10: 2040622319880382. doi:10.1177/2040622319880382
11. Garcia-Canton C, Rodenas A, Lopez-Aperador C, et al. Frailty in hemodialysis and prediction of poor short-term outcome: mortality, hospitalization and visits to hospital emergency services. Ren Fail. 2019; 41(1):567-575. doi:10.1080/0886022X.2019.1628061
12. Aygör HE, Fadıloğlu Ç, Şahin S, Aykar F, Akçiçek F. Validation of Edmonton frail scale into elderly turkish population. Arch Gerontol Geriatr. 2018;76:133-137. doi:10.1016/j.archger.2018.02.003
13. Anderson BM, Qasim M, Correa G, et al. Correlations, agreement and utility of frailty instruments in prevalent haemodialysis patients: baseline cohort data from the FITNESS study. Clin Kidney J. 2022;15(1): 145-152. doi:10.1093/ckj/sfab137
14. Kennard AL, Rainsford S, Glasgow NJ, Talaulikar GS. Use of frailty assessment instruments in nephrology populations: a scoping review. BMC Geriatr. 2023;23(1):449. doi:10.1186/s12877-023-04101-y
15. Chu NM, Chen X, Norman SP, et al. Frailty prevalence in younger end-stage kidney disease patients undergoing dialysis and transplantation. Am J Nephrol. 2020;51(7):501-510. doi:10.1159/000508576
16. Chao CT, Hsu YH, Chang PY, et al. Simple self-report FRAIL scale might be more closely associated with dialysis complications than other frailty screening instruments in rural chronic dialysis patients. Nephrology (Carlton). 2015;20(5):321-328. doi:10.1111/nep.12401
17. Kang SH, Do JY, Lee SY, Kim JC. Effect of dialysis modality on frailty phenotype, disability, and health-related quality of life in maintenance dialysis patients. PLoS One. 2017;12(5):e0176814. doi:10.1371/journal.pone.0176814
18. Lee SY, Yang DH, Hwang E, et al. The prevalence, association, and clinical outcomes of frailty in maintenance dialysis patients. J Ren Nutr. 2017;27(2):106-112. doi:10.1053/j.jrn.2016.11.003
19. Johansen KL, Chertow GM, Jin C, Kutner NG. Significance of frailty among dialysis patients. J Am Soc Nephrol. 2007;18(11):2960-2967. doi: 10.1681/ASN.2007020221
20. Gesualdo GD, Duarte JG, Zazzetta MS, Kusumota L, Orlandi FS. Frailty and associated risk factors in patients with chronic kidney disease on dialysis. Cien Saude Colet. 2020;25(11):4631-4637. doi:10.1590/1413-812320202511.03482019
21. Ren H, Gong D, Jia F, Xu B, Liu Z. Sarcopenia in patients undergoing maintenance hemodialysis: incidence rate, risk factors and its effect on survival risk. Ren Fail. 2016;38(3):364-371. doi:10.3109/0886022X.2015. 1132173
22. Lamarca F, Carrero JJ, Rodrigues JC, Bigogno FG, Fetter RL, Avesani CM. Prevalence of sarcopenia in elderly maintenance hemodialysis patients: the impact of different diagnostic criteria. J Nutr Health Aging. 2014;18(7):710-717. doi:10.1007/s12603-014-0505-5
23. Yasar E, Tek NA, Tekbudak MY, et al. The relationship between myostatin, inflammatory markers, and sarcopenia in patients with chronic kidney disease. J Ren Nutr. 2022;32(6):677-684. doi:10.1053/j.jrn.2022.01.011
24. Lee HJ, Son YJ. Prevalence and associated factors of frailty and mortality in patients with end-stage renal disease undergoing hemodialysis: a systematic review and meta-analysis. Int J Environ Res Public Health. 2021;18(7):3471. doi:10.3390/ijerph18073471
25. Blaum CS, Xue QL, Tian J, Semba RD, Fried LP, Walston J. Is hyperglycemia associated with frailty status in older women? J Am Geriatr Soc. 2009;57(5):840-847. doi:10.1111/j.1532-5415.2009.02196.x
26. Davenport A. Frailty, appendicular lean mass, osteoporosis and osteosarcopenia in peritoneal dialysis patients. J Nephrol. 2022;35(9): 2333-2340. doi:10.1007/s40620-022-01390-1